IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,290,475 | +130.7% | 6,233,146 | +14.0% | 0.01% | +200.0% |
| Q2 2023 | $103,739,646 | +30.0% | 5,468,616 | +6.3% | 0.00% | 0.0% |
| Q1 2023 | $79,778,926 | -11.3% | 5,143,709 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $89,976,862 | +303.1% | 5,069,119 | +26.7% | 0.00% | +100.0% |
| Q3 2022 | $22,322,000 | +43.1% | 4,000,450 | +0.0% | 0.00% | – |
| Q2 2022 | $15,597,000 | -24.8% | 3,999,493 | +6.2% | 0.00% | – |
| Q1 2022 | $20,750,000 | -36.5% | 3,765,713 | -1.8% | 0.00% | -100.0% |
| Q4 2021 | $32,667,000 | +0.3% | 3,834,119 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $32,581,000 | -23.0% | 3,749,286 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $42,288,000 | -34.0% | 4,000,697 | +0.1% | 0.00% | -50.0% |
| Q1 2021 | $64,107,000 | -64.2% | 3,996,720 | +3.0% | 0.00% | -60.0% |
| Q4 2020 | $179,150,000 | +60.1% | 3,878,549 | +21.9% | 0.01% | +25.0% |
| Q3 2020 | $111,927,000 | +172.0% | 3,180,644 | +88.2% | 0.00% | +300.0% |
| Q2 2020 | $41,155,000 | – | 1,690,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |